Publication: Liver transplantation and atrial fibrillation: A meta-analysis
Issued Date
2018-10-01
Resource Type
ISSN
19485182
Other identifier(s)
2-s2.0-85055716611
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
World Journal of Hepatology. Vol.27, No.10 (2018), 761-771
Suggested Citation
Ronpichai Chokesuwattanaskul, Charat Thongprayoon, Tarun Bathini, Patompong Ungprasert, Konika Sharma, Karn Wijarnpreecha, Pavida Pachariyanon, Wisit Cheungpasitporn Liver transplantation and atrial fibrillation: A meta-analysis. World Journal of Hepatology. Vol.27, No.10 (2018), 761-771. doi:10.4254/wjh.v10.i10.761 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46303
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Liver transplantation and atrial fibrillation: A meta-analysis
Abstract
© The Author(s) 2018. AIM To assess prevalence of pre-existing atrial fibrillation (AF) and/or incidence of AF following liver transplantation, and the trends of patient's outcomes overtime; to evaluate impact of pre-existing AF and post-operative AF on patient outcomes following liver transplantation. METHODS A literature search was conducted utilizing MEDLINE, EMBASE and Cochrane Database from inception through March 2018. We included studies that reported: (1) prevalence of pre-existing AF or incidence of AF following liver transplantation; or (2) outcomes of liver transplant recipients with AF. Effect estimates from the individual study were extracted and combined utilizing randomeffect, generic inverse variance method of DerSimonian and Laird. The protocol for this meta-analysis is registered with PROSPERO (International Prospective Register of Systematic Reviews, No. CRD42018093644). RESULTS Twelve observational studies with a total of 38586 liver transplant patients were enrolled. Overall, the pooled estimated prevalence of pre-existing AF in patients undergoing liver transplantation was 5.4% (95%CI: 4.9%-5.9%) and pooled estimated incidence of AF following liver transplantation was 8.5% (95%CI: 5.2%-13.6%). Meta-regression analyses were performed and showed no significant correlations between year of study and either prevalence of pre-existing AF (P = 0.08) or post-operative AF after liver transplantation (P = 0.54). The pooled OR of mortality among liver transplant recipients with pre-existing AF was 2.34 (2 studies; 95%CI: 1.10-5.00). In addition, pre-existing AF is associated with postoperative cardiovascular complications among liver transplant recipients (3 studies; OR: 5.15, 95%CI: 2.67-9.92, I 2 = 64%). With limited studies, two studies suggested significant association between new-onset AF and poor clinical outcomes including mortality, cerebrovascular events, post-transplant acute kidney injury, and increased risk of graft failure among liver transplant recipients (P < 0.05). CONCLUSION The overall estimated prevalence of pre-existing AF and incidence of AF following liver transplantation are 5.4% and 8.5%, respectively. Incidence of AF following liver transplant does not seem to decrease overtime. Preexisting AF and new-onset AF are potentially associated with poor clinical outcomes post liver transplantation.